Case report · 30 Jun 2025
Conference abstractPublished 14 Mar 2024
Stem cells and cancer
Hiorca Stem Cell Research Centre, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
This comprehensive Abstract provides a detailed overview of stem cell treatments for leukaemia, spanning its foundations, current practices, and promising future innovations. The current findings in medical research appear to be a testament to the continuous pursuit of effective and curative therapies for leukaemia, offering insight into the ground-breaking research shaping the landscape of leukaemia treatment. Leukaemia, an intricate and formidable haematological malignancy, defies conventional treatment modalities such as chemotherapy and radiation therapy. This cancer arises in the bone marrow, where aberrant blood cells usurp the space of their healthy counterparts, instigating life-threatening complications. In re-cent years, hematopoietic stem cell transplantation (HSCT), colloquially known as stem cell transplantation, has emerged as a beacon of hope amidst this clinical challenge. The crux of stem cell transplantation embodies its potential as a curative strategy for leukaemia. It offers a unique approach aimed at supplanting the malevolent cells that lay siege to the hematopoietic system with healthy, functional counterparts. This reinstatement of normal haematopoiesis promises a new lease on life to leukaemia patients who have grappled with the grim spectre of this relentless malady. The fundamental concept un-derpinning stem cell transplantation is elegantly simple: the infusion of healthy stem cells, capable of generating all types of blood cells, into the patient's bloodstream. These remarkable cells, when introduced, discern the beleaguered bone marrow as their canvas for regeneration and rejuvenation. It mirrors the act of revitalizing a languishing garden with seeds of vitality. Nonetheless, the success of stem cell transplantation is far from universal. It hinges upon a labyrinth of influential variables, encompassing the specific leukaemia type and stage, the patient's age, overall health, and the providence of compatible stem cell donors. Thus, while the concept is compelling, its operational reality pivots upon the meticulous orchestration of these critical factors.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 22 Nov 2024
Role of Ovarian Cancer Stem Cells in Tumor Recurrence and Therapy Resistance
Article · 22 Nov 2024
Ovarian Cancer Stem Cells: Their Role in Tumor Recurrence and Resistance
Conference abstract · 15 Sep 2018
Cancer stem cells in breast and gynecological cancers: How to individualize treatment based on the sensitivity of patient’s CSCs
Conference abstract · 29 Aug 2017
Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum-response
More from this journal
The newest in Gynecology & Obstetrics.
Short communication · 30 Apr 2026
Vitamin D and Polycystic Ovary Syndrome: A Research Progress Review
Conference abstract · 19 Nov 2025
Loss of lncRNAs 1700101O22Rik and 1700027A15Rik causes sperm malformation and subfertility
Conference abstract · 19 Nov 2025
Linking Mitochondrial Fatty Acid Metabolism to Follicular Health: A Novel Perspective on Premature Ovarian Insufficiency
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalGynecology & Obstetrics
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Prithiv Kumar”

